Nephrol Dial Transplant (2004) 19: 413-420
© ERA–EDTA 2004; all rights reserved
Original Article
Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments
1Division of Nephrology, Tufts-New England Medical Center, Boston, MA, USA, 3Johns Hopkins Medical Institutions, Baltimore, MD, USA, 2University of New Mexico, Albuquerque, NM, USA and 4Dialysis Clinic, Inc., Nashville, TN, USA
Correspondence and offprint requests to: Dana Miskulin, MD, MS, New England Medical Center, Division of Nephrology, Box 391, 750 Washington Street, Boston, MA 02111, USA. Email: dmiskulin{at}tufts-nemc.org
Background. A valid and practical measure of comorbid illness burden in dialysis populations is greatly needed to enable unbiased comparisons of clinical outcomes. We compare the discriminatory accuracy of 1 year mortality predictions derived from four comorbidity instruments in a large representative US dialysis population.
Methods. Comorbidity information was collected using the Index of Coexistent Diseases (ICED) in 1779 haemodialysis patients of a national dialysis provider between 1997 and 2000. Comorbidity was also scored according to the Charlson Comorbidity Index (CCI), Wright-Khan and Davies indices. Relationships of instrument scores with 1 year mortality were assessed in separate logistic regression analyses. Discriminatory ability was compared using the area under the receiver-operating characteristics curve (AUC), based on predictions of each regression model.
Results. When mortality was predicted using comorbidity and age, the ICED better discriminated between survivors and those who died (AUC 0.72) as compared with the CCI (0.67), Wright-Khan (0.68) and Davies (0.68) indices. Upon addition of race and serum albumin, predictive accuracy of each model improved further (AUCs of the ICED, 0.77; CCI, 0.75; Wright-Khan Index, 0.75; Davies Index, 0.74).
Conclusions. The ICED had greater discriminatory ability than the CCI, Davies and Wright-Khan indices, when age and a comorbidity index were used alone to predict 1 year mortality; however, the differences among instruments diminished once serum albumin, race and the cause of ESRD were accounted for. None of the currently available comorbidity instruments tested in this study discriminated mortality outcomes particularly well. Assessing comorbidity using the ICED takes significantly more time. Identifying the key prognostic comorbid conditions and weighting these according to outcomes in a dialysis population should increase accuracy and, with restriction to a finite number of items, provide a practical means for widespread comorbidity assessment.
Keywords: case-mix severity; comorbidity; risk stratification
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Jain, P. Cockwell, J. Little, M. Ferring, J. Nicholas, N. Richards, R. Higgins, and S. Smith Survival and transplantation in end-stage renal disease: a prospective study of a multiethnic population Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3840 - 3846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Chan, J. M. Lazarus, R. Thadhani, and R. M. Hakim Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation J. Am. Soc. Nephrol., October 1, 2009; 20(10): 2223 - 2233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. F. Morrone, S. Mazzaferro, D. Russo, F. Aucella, M. Cozzolino, M. G. Facchini, A. Galfre, F. Malberti, M. C. Mereu, M. Nordio, et al. Interaction between parathyroid hormone and the Charlson comorbidity index on survival of incident haemodialysis patients Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2859 - 2865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Argyropoulos, C.-C. H. Chang, L. Plantinga, N. Fink, N. Powe, and M. Unruh Considerations in the Statistical Analysis of Hemodialysis Patient Survival J. Am. Soc. Nephrol., September 1, 2009; 20(9): 2034 - 2043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Chan, J. M. Lazarus, R. Thadhani, and R. M. Hakim Anticoagulant and Antiplatelet Usage Associates with Mortality among Hemodialysis Patients J. Am. Soc. Nephrol., April 1, 2009; 20(4): 872 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tsukamoto End-stage renal disease (ESRD) and its treatment in Japan Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2447 - 2450. [Full Text] [PDF]
|
|
|
|
|
|
M. L. Melamed, J. A. Eustace, L. C. Plantinga, B. G. Jaar, N. E. Fink, R. S. Parekh, J. Coresh, Z. Yang, T. Cantor, and N. R. Powe Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1650 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M Mauri, M. Cleries, E. Vela, and C. R. Registry Design and validation of a model to predict early mortality in haemodialysis patients Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1690 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tomson, U. Udayaraj, J. Gilg, and D. Ansell Comorbidities in UK patients at the start of renal replacement therapy (Chapter 6) Nephrol. Dial. Transplant., August 1, 2007; 22(suppl_7): vii58 - vii68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. van Manen, P. C. W. van Dijk, V. S. Stel, F. W. Dekker, M. Cleries, F. Conte, T. Feest, R. Kramar, T. Leivestad, J. D. Briggs, et al. Confounding effect of comorbidity in survival studies in patients on renal replacement therapy Nephrol. Dial. Transplant., January 1, 2007; 22(1): 187 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Geddes, P. C. W. van Dijk, S. McArthur, W. Metcalfe, K. J. Jager, A. H. Zwinderman, M. Mooney, J. G. Fox, and K. Simpson The ERA-EDTA cohort study--comparison of methods to predict survival on renal replacement therapy Nephrol. Dial. Transplant., April 1, 2006; 21(4): 945 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wu, I. Evans, R. Joseph, R. Shapiro, H. Tan, A. Basu, C. Smetanka, A. Khan, J. McCauley, and M. Unruh Comorbid Conditions in Kidney Transplantation: Association with Graft and Patient Survival J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3437 - 3444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Weisbord, L. F. Fried, R. M. Arnold, M. J. Fine, D. J. Levenson, R. A. Peterson, and G. E. Switzer Prevalence, Severity, and Importance of Physical and Emotional Symptoms in Chronic Hemodialysis Patients J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2487 - 2494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Himmelfarb, B. J.G. Pereira, D. E. Wesson, P. C. Smedberg, and W. L. Henrich Payment for Quality in End-Stage Renal Disease J. Am. Soc. Nephrol., December 1, 2004; 15(12): 3263 - 3269. [Full Text] [PDF]
|
|